Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington.
Mass Spectrom Rev. 2014 Mar-Apr;33(2):98-109. doi: 10.1002/mas.21382. Epub 2013 Sep 30.
The post-translational modifications (PTMs) of cysteine residues include oxidation, S-glutathionylation, S-nitrosylation, and succination, all of which modify protein function or turnover in response to a changing intracellular redox environment. Succination is a chemical modification of cysteine in proteins by the Krebs cycle intermediate, fumarate, yielding S-(2-succino)cysteine (2SC). Intracellular fumarate concentration and succination of proteins are increased by hyperpolarization of the inner mitochondrial membrane, in concert with mitochondrial, endoplasmic reticulum (ER) and oxidative stress in 3T3 adipocytes grown in high glucose medium and in adipose tissue in obesity and diabetes in mice. Increased succination of proteins is also detected in the kidney of a fumarase deficient conditional knock-out mouse which develops renal cysts. A wide range of proteins are subject to succination, including enzymes, adipokines, cytoskeletal proteins, and ER chaperones with functional cysteine residues. There is also some overlap between succinated and glutathionylated proteins, suggesting that the same low pKa thiols are targeted by both. Succination of adipocyte proteins in diabetes increases as a result of nutrient excess derived mitochondrial stress and this is inhibited by uncouplers, which discharge the mitochondrial membrane potential (ΔΨm) and relieve the electron transport chain. 2SC therefore serves as a biomarker of mitochondrial stress or dysfunction in chronic diseases, such as obesity, diabetes, and cancer, and recent studies suggest that succination is a mechanistic link between mitochondrial dysfunction, oxidative and ER stress, and cellular progression toward apoptosis. In this article, we review the history of the succinated proteome and the challenges associated with measuring this non-enzymatic PTM of proteins by proteomics approaches.
半胱氨酸残基的翻译后修饰(PTMs)包括氧化、S-谷胱甘肽化、S-亚硝化和琥珀酰化,所有这些修饰都可以根据细胞内氧化还原环境的变化来改变蛋白质的功能或周转率。琥珀酰化是一种蛋白质中半胱氨酸的化学修饰,由三羧酸循环中间体富马酸盐修饰,生成 S-(2-琥珀酰)半胱氨酸(2SC)。在高葡萄糖培养基中培养的 3T3 脂肪细胞和肥胖和糖尿病小鼠的脂肪组织中,通过线粒体内膜去极化,与线粒体、内质网(ER)和氧化应激协同作用,细胞内富马酸盐浓度和蛋白质的琥珀酰化增加。在缺乏琥珀酸酶的条件性敲除小鼠的肾脏中也检测到蛋白质琥珀酰化增加,这种小鼠会发展出肾囊肿。广泛的蛋白质受到琥珀酰化的影响,包括酶、脂肪因子、细胞骨架蛋白和具有功能性半胱氨酸残基的 ER 伴侣蛋白。琥珀酰化蛋白和谷胱甘肽化蛋白之间也有一些重叠,这表明这两种修饰都靶向相同的低 pKa 巯基。糖尿病中脂肪细胞蛋白的琥珀酰化随着源自线粒体应激的营养过剩而增加,而解偶联剂可以抑制这种增加,解偶联剂会排出线粒体膜电位(ΔΨm)并缓解电子传递链。因此,2SC 可作为慢性疾病(如肥胖症、糖尿病和癌症)中线粒体应激或功能障碍的生物标志物,最近的研究表明,琥珀酰化是线粒体功能障碍、氧化和 ER 应激以及细胞向凋亡进展之间的机制联系。在本文中,我们回顾了琥珀酰化蛋白质组的历史以及通过蛋白质组学方法测量这种非酶促蛋白质翻译后修饰所面临的挑战。